Several classical quinazoline analogues of folic acid bearing chloro or methyl substituents at position 5 were evaluated as inhibitors of the growth of four human gastrointestinal adenocarcinoma cell lines in vitro. The preparation of two of these, 5-chloro-5,8-dideazaisofolic acid, 1e, and 5-chloro-5,8-dideazaisoaminopterin, 2a, is reported for the first time. In addition, a new synthetic route to 5-chloro-5,8-dideazaaminopterin, 2b, is described. For compounds having a 2,4-diamino configuration, the presence of chlorine at position 5 afforded superior growth inhibitory potency. However, compound 1e was substantially less effective than its 5-methyl counterpart.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm00391a042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dihydrofolate reductase inhibitory potential of 1H-indole-based-meldrum linked 1H-1,2,3-triazoles as new anticancer derivatives: In-vitro and in-silico studies.
Eur J Med Chem
February 2025
Natural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, 616, Nizwa, Oman. Electronic address:
In this present work, we describe the syntheses of a new series of 32 1H-indole-based-meldrum linked 1H-1,2,3-triazole derivatives (2-13, 15a-15f, 16a-16f, 17a-17f and 19a, 19b, 20a), which constitute a new class of 1H-1,2,3-triazoles. Compounds 15a-15f, 16a-16f, 17a-17f have been prepared by employing "click" reactions between substituted 1H-indole-based meldrum alkynes (11, 12 and 13) and substituted aromatic azides (14a-14f) in the presence of copper iodide (CuI) and Hünig's base. Then, the synthesis of compounds 19, 20 through decomposition of meldrum moiety.
View Article and Find Full Text PDFQuantum dot-based conjugates: Luminous nanotools for cancer research.
Biochem Biophys Res Commun
December 2024
Biomedical Nanotechnology Research Group (NanoBio), Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil; Departamento de Biofísica e Radiobiologia, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil. Electronic address:
Article Synopsis
- * QDs possess unique optical properties and reactive surfaces that allow them to be conjugated with various biomolecules, facilitating their application in multimodal diagnostics and biosensing for early cancer detection and personalized treatment.
- * The review discusses the diverse capabilities of QDs in cancer research, highlighting their conjugation with different types of molecules and presenting an overview of their properties and potential for improving diagnostic and therapeutic strategies in oncology.
Associations between folate intake and knee pain, inflammation mediators and comorbid conditions in patients with symptomatic knee osteoarthritis.
BMC Musculoskelet Disord
November 2024
Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, Guangdong, China.
Background: To investigate the associations between folate intake and changes in knee pain, inflammation mediators and comorbid conditions over 2 years in patients with symptomatic knee osteoarthritis (OA).
Methods: A post-hoc analysis was performed based on data from the VIDEO study, a multicenter, randomized, double-blind, placebo-controlled clinical trial aimed at assessing the impact of vitamin D supplementation on patients with knee OA who were also vitamin D deficient. The original trial's design and inclusion and exclusion criteria were integrated into this subsequent post-hoc analysis.
Efficient and selective kidney targeting by chemically modified carbohydrate conjugates.
Mol Ther
December 2024
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA. Electronic address:
Article Synopsis
- * The experiments demonstrated that RENTAC conjugates were taken up by kidney cells through certain receptors and remained in the kidneys longer than in other organs, confirming their selective distribution.
- * In a kidney fibrosis model, using RENTAC to deliver a targeted treatment slowed disease progression and reduced collagen buildup without any negative effects, suggesting potential clinical uses for kidney-targeted therapies.
Evaluation of UCP1162, a potent propargyl-linked inhibitor of dihydrofolate reductase with potential application to cancer and autoimmune disease.
Biochem Pharmacol
December 2024
Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, United States. Electronic address:
Cellular resistance can limit the effectiveness of antifolate drugs for the treatment of cancer and autoimmune diseases. We examined the biochemical and cellular effects of a propargyl linked, non-classical antifolate UCP1162 that shows exceptional potency and resilience in the background of methotrexate resistance. UCP1162 inhibited the human DHFR enzyme with affinity and kinetics comparable to methotrexate (MTX).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!